Drug Profile
Rebonuputemcel - DiscGenics
Alternative Names: IDCT; IDCT-001; Injectable discogenic cell therapy - DiscGenicsLatest Information Update: 08 Jan 2024
Price :
$50
*
At a glance
- Originator DiscGenics
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Intervertebral disc degeneration
- No development reported Spinal disorders